SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000904454-17-000211
Filing Date
2017-03-06
Accepted
2017-03-06 17:11:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G s13g_030617-myovant.htm SC 13G 34897
  Complete submission text file 0000904454-17-000211.txt   36444
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 (441) 824-8101
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-89732 | Film No.: 17668755
SIC: 2834 Pharmaceutical Preparations

Mailing Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152
Business Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152 41-44-555-10-00
Takeda Pharmaceuticals International AG (Filed by) CIK: 0001688140 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 0331
Type: SC 13G